Podophyllum Resin Topical Tincture — FDA Drug Shortage

To Be Discontinued — Padagis US LLC

The FDA lists a drug shortage record for Podophyllum Resin Topical Tincture from Padagis US LLC with status To Be Discontinued. The shortage was first posted on Jul 23, 2026.

Shortage details

Status
To Be Discontinued
Company
Padagis US LLC
Package NDC
0574-0601-15
Presentation
Podocon 25, Topical Tincture, 1 mg/4 mL (NDC 0574-0601-15)
Initial Posting
Jul 23, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.